Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody
OSS, Netherlands–(BUSINESS WIRE)–http://www.citryll.com/ announced today the first closing of a targeted € 15 million investment round, funded by ModiQuest B.V.,…